why choose us

First received: September 26, 2022

Clinical Trial: CMV CTLs in Neonates With CMV Infection

Study Status: Completed

Recruit Status: RECRUITING

Condition: Congenital Cytomegaloviral (CMV) Disease

Study Type: INTERVENTIONAL


Official Title: A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe

Brief Summary: Patients with moderate or severe CMV disease less than 21 days old who have a maternal donor who has a CMV response to the peptivators will be screened.All patients will receive treatment with valganciclovir or ganciclovir.There is a safety run in with treatment with CMV CTLs in cohort 1 and if found to be safe, will proceed to cohort 2 for randomization to receive antiviral therapy with or without CMV CTLs.

Read more